Heron Therapeutics | HRTX - Interest Income


Heron Therapeutics reported $433K in Interest Income for its fiscal quarter ending in December of 2021.





Interest Income Change Date
ALKERMES USD 11.94M 853K Sep/2025
Alnylam Pharmaceuticals USD 28.68M 1.19M Sep/2025
Amarin USD 3.37M 3.37M Dec/2024
Arrowhead Research USD 9.05M 1.97M Sep/2025
Eisai JPY 3.11B 783M Mar/2024
Esperion Therapeutics USD -0.15 0.18 Sep/2024
GlaxoSmithKline GBP 26M 24M Sep/2025
Heron Therapeutics USD 433K 277K Dec/2021
Insmed USD 765K 55K Sep/2024
Ligand Pharmaceuticals USD 3.87M 2.25M Sep/2025
Merck USD 96M 27M Sep/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Pacira USD 8.53M 3.53M Sep/2025
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Ultragenyx Pharmaceutical USD 5.86M 69K Sep/2025
Veracyte USD 3.48M 545K Sep/2025
Vertex Pharmaceuticals USD 125.7M 3.3M Sep/2025